THE effect of vaccination with diphtheria toxoid (AD-M) on TNF and IL-6 production has been studied in humans. In the present study it was demonstrated that immunization with AD-M resulted in changes of in vitro TNF and IL-6 production by peripheral blood mononuclear cells. TNF release was suppressed but IL-6 production was stimulated. On the other hand, serum levels of TNF were markedly increased over a period of 3
Introduction
The safety of vaccination in the first instance depends on the vaccine's characteristics. It is well known, however, that the vaccine's application always switches on a cascade of events which results in cytokine release. Thus, the spontaneous production of high levels of IL-4 and TNF-z after measles virus vaccination has been shown. The transient increase of serum has been also demonstrated after vaccination with brucella antigenic extracts and live, attenuated Francisella tularensis in mice and humans. 2'3 Murine spleen cells taken at intervals after infection and cultured with brucella antigens produced elevated levels of IL-1, IL-6 and TNF-z2. These cytokines play an important role in the development of inflammation. 4 The inflammatory reactions, which are safe for healthy individuals, may entail serious consequences in children with a variety of forms of immune disturbance. Production of at least one of the aforesaid proinflammatory cytokines may be regulated with a new immunomodulating agent thymohexin (Imunofan(R)). This synthetic hexapeptid is a modified analogue of the thymopoietin II active centre. 5 The inhibitory effect of imunofan (IF) on TNF-ct production in septic patients has been shown. 6 In the present study, we investigated TNF and IL-6 production after diphtheria toxoid vaccination and the possibility of cytokine level modulation by IF pretreatment. (Fig. 3) . In general, the serum level of IL-6 in vaccinated volunteers receiving IF was lower than in individuals injected with AD-M only (Fig. 4) 
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